HMBOX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.101780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.547030E-01
Normal-vs-Stage2
1.301010E-01
Normal-vs-Stage3
1.625160E-01
Normal-vs-Stage4
7.640000E-01
Stage1-vs-Stage2
7.283200E-01
Stage1-vs-Stage3
1.920370E-01
Stage1-vs-Stage4
7.231800E-02
Stage2-vs-Stage3
7.436100E-04
Stage2-vs-Stage4
1.926160E-02
Stage3-vs-Stage4
6.843700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.542200E-02
Normal-vs-AfricanAmerican
6.195000E-01
Normal-vs-Asian
1.802370E-01
Caucasian-vs-AfricanAmerican
2.017600E-01
Caucasian-vs-Asian
8.909800E-01
AfricanAmerican-vs-Asian
3.203000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.041950E-01
Normal-vs-Female
1.381820E-01
Male-vs-Female
5.825400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.653360E-01
Normal-vs-Age(41-60Yrs)
3.354400E-01
Normal-vs-Age(61-80Yrs)
7.009600E-02
Normal-vs-Age(81-100Yrs)
1.530070E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.734000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.653200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.263800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.966180E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.217300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.149000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.016400E-02
Normal-vs-Daily Drinker
7.323700E-02
Normal-vs-Weekly Drinker
2.350200E-01
Normal-vs-Occasional Drinker
2.827800E-01
Normal-vs-Social Drinker
3.377200E-01
Non Drinker-vs-Daily Drinker
4.914800E-01
Non Drinker-vs-Weekly Drinker
5.149400E-01
Non Drinker-vs-Occasional Drinker
3.058600E-01
Non Drinker-vs-Social Drinker
2.944200E-01
Daily Drinker-vs-Weekly Drinker
3.078000E-01
Daily Drinker-vs-Occasional Drinker
1.745980E-01
Daily Drinker-vs-Social Drinker
1.816800E-01
Weekly Drinker-vs-Occasional Drinker
8.054000E-01
Weekly Drinker-vs-Social Drinker
7.635600E-01
Occasional Drinker-vs-Social Drinker
9.386000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.775020E-01
Normal-vs-Grade 2
4.015500E-02
Normal-vs-Grade 3
5.751600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.898500E-02
Grade 1-vs-Grade 3
3.352400E-02
Grade 1-vs-Grade 4
1.775020E-01
Grade 2-vs-Grade 3
4.398600E-01
Grade 2-vs-Grade 4
4.015500E-02
Grade 3-vs-Grade 4
5.751600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.935600E-02
Normal-vs-NonDiabetic
9.170200E-02
Diabetic-vs-NonDiabetic
6.641800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.927500E-02
Normal-vs-NoPancreatitis
1.043040E-01
Pancreatitis-vs-NoPancreatitis
3.753400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.830000E-02
Normal-vs-N1
1.440170E-01
N0-vs-N1
3.446200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.719240E-01
Normal-vs-TP53-NonMutant
1.345990E-01
TP53-Mutant-vs-TP53-NonMutant
5.697800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
